Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2018

Aug 14, 2018

SELL
$50.53 - $62.98 $65,234 - $81,307
-1,291 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$59.92 - $68.98 $77,356 - $89,053
1,291 New
1,291 $82,000

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Aristotle Capital Management, LLC Portfolio

Follow Aristotle Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aristotle Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aristotle Capital Management, LLC with notifications on news.